Oral Dosage Innovation for Pediatric Drug Delivery
Pediatric drug development isn’t just about reducing adult doses. It involves unique technical, regulatory, and manufacturing challenges that require creative formulation strategies. In this webinar, experts from AustinPx and Via Therapeutics explore the complex development of clofazimine mini-tablets for pediatric use, covering solubility issues, stability hurdles, and process optimization from early formulation through clinical manufacturing.…
Read MoreData-Driven Development of Clofazimine: A High-Drug Load Pediatric Mini-Tablet
The development of clofazimine pediatric mini-tablets demonstrates a data-driven approach to pharmaceutical development. By leveraging predictive tools and iterative design, AustinPx transformed a formulation-challenged compound into a scalable, patient-friendly product suitable for clinical trials.
Read MoreHow to Solve Complex Pediatric Dosing Challenges Using Tailored Solutions
In this article, Dave Miller, Ph.D. (CSO, AustinPx) explores why pediatric drug development demands more than simply reducing an adult dose. From palatability and swallowability to the precision required for weight-based dosing, these projects carry unique scientific, regulatory, and manufacturing hurdles. The piece highlights how mini tablets can offer the stability, flexibility, and patient compliance…
Read More